Name: UMIN ID:
Unique ID issued by UMIN | UMIN000014763 |
---|---|
Receipt number | R000017165 |
Scientific Title | The Randomized Controlled Trial for Evaluating the Efficacies of Tolvaptan in Patients with Chronic Kidney Disease |
Date of disclosure of the study information | 2014/08/05 |
Last modified on | 2022/03/16 13:32:05 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/08/05 15:32:22 | ||
2 | Update | 2014/08/06 13:52:27 | Recruitment status |
|
3 | Update | 2015/08/17 15:11:44 | Last follow-up date |
|
4 | Update | 2015/08/17 15:12:48 | Key inclusion criteria |
|
5 | Update | 2015/08/17 15:13:22 | Name of person sending information Name of person sending information |
|
6 | Update | 2015/08/17 15:17:00 | Institute Institute |
|
7 | Update | 2017/02/06 09:11:44 | Last follow-up date |
|
8 | Update | 2019/01/29 10:01:21 | Name of primary person or sponsor Organization Institutions |
|
9 | Update | 2019/12/11 14:28:48 | Date of IRB Last follow-up date |
|
10 | Update | 2020/02/10 09:20:05 | Last follow-up date |
|
11 | Update | 2020/08/11 15:24:09 | Recruitment status |
|
12 | Update | 2021/08/10 09:39:19 | Number of participants that the trial has enrolled |
|
13 | Update | 2022/02/09 15:23:17 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Name of person sending information Name of person sending information Organization Organization Division name Division name Address Address TEL Organization1 Address1 Tel1 Email1 Organization Organization Address Address Tel |
|
14 | Update | 2022/02/09 15:48:15 | 1st name of lead principal investigator |
|
15 | Update | 2022/03/16 13:32:05 | Division name |